Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Uwe PelzerHelmut Oettle

Abstract

Gemcitabine usually given until progressive disease (PD) is the main first-line treatment option for patients with inoperable advanced pancreatic cancer (APC). Currently there is no accepted active regimen for second-line chemotherapy. Previous phase II studies suggest clinical relevant activity of oxaliplatin, folinic acid and 5-FU (OFF). We initiated a phase III multicentre study comparing OFF versus best supportive care (BSC) in patients with APC progressing while on gemcitabine therapy. In this open randomized study, patients with CT and/or MRI confirmed progressive disease while on gemcitabine therapy were randomized 1:1 to OFF or BSC. Stratification included duration of first-line therapy (<3, 3 to 6 and >6 months), performance status (KPS 70-80%; 90-100%) and tumour stage (M1/M0). OFF consisted of folinic acid 200mg/m(2) followed by 5-fluorouracil 2g/m(2) (24h) on d1, d8, d15, d22 and oxaliplatin 85 mg/m(2) on days 8 and 22. After a rest of 3 weeks the next cycle was started on d43. A total of 165 patients were calculated to demonstrate a doubling of survival time after progression on first-line therapy. After inclusion of forty six patients the trial was terminated according to predefined protocol regulations due to ins...Continue Reading

References

Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeCharles S Fuchs
Apr 10, 2008·Cancer Chemotherapy and Pharmacology·Chigusa MorizaneEiichiro Suzuki
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David CunninghamJohn P Neoptolemos
Jan 27, 2010·Nature Reviews. Clinical Oncology·Anastasios Stathis, Malcolm J Moore

❮ Previous
Next ❯

Citations

Jan 4, 2008·Cancer Chemotherapy and Pharmacology·M ReniS Grisanti
Apr 10, 2008·Cancer Chemotherapy and Pharmacology·Chigusa MorizaneEiichiro Suzuki
May 12, 2012·Cancer Chemotherapy and Pharmacology·Alberto ZaniboniRoberto Labianca
Sep 3, 2013·Cancer Chemotherapy and Pharmacology·Naminatsu TakaharaKazuhiko Koike
May 1, 2013·Nature Reviews. Clinical Oncology·Jens WernerMarkus W Büchler
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T SeufferleinUNKNOWN ESMO Guidelines Working Group
May 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O E RahmaT F Greten
Sep 29, 2011·The Cancer Journal·Cecilia Larocca, Jeffrey Schlom
Nov 29, 2012·The Cancer Journal·Kevin M Sullivan, Peter S Kozuch
Jul 2, 2014·Deutsches Ärzteblatt International·Thomas SeufferleinWaldemar Uhl
Jan 9, 2014·Der Internist·U PelzerH Riess
Feb 25, 2014·Cancer Chemotherapy and Pharmacology·Heloisa P SoaresCaio M Rocha-Lima
Mar 17, 2012·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Richard FischerJan Harder
May 24, 2014·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Anne Katrin BergerChristoph Springfeld
Jun 12, 2014·Cancer Immunology, Immunotherapy : CII·Moon Jae ChungSi Young Song
Jan 22, 2014·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Khurum KhanStan B Kaye
Apr 15, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M BenavidesE Aranda
Jun 1, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M FrigeriP Saletti
Oct 29, 2014·Journal of Comparative Effectiveness Research·Katherine E Reeder-HayesAmir H Khandani
Aug 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VivaldiE Vasile
Aug 21, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A LamarcaJ W Valle
Mar 8, 2014·World Journal of Gastroenterology : WJG·Evan J Walker, Andrew H Ko
Mar 8, 2014·World Journal of Gastroenterology : WJG·Marwan GhosnDolly Nasr
Dec 25, 2015·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Kyoichi TakaoriUNKNOWN IAP/EPC study group on the clinical managements of pancreatic cancer
Nov 13, 2014·Scandinavian Journal of Gastroenterology·Constantin Maier-StockerRuben R Plentz
Jun 19, 2014·Expert Review of Clinical Pharmacology·Muhammad Wasif Saif
Sep 2, 2015·Expert Review of Anticancer Therapy·Concetta Elisa OnestiPaolo Marchetti
Nov 28, 2012·Expert Review of Anticancer Therapy·Rahma Warsame, Axel Grothey
Jun 12, 2013·Expert Review of Vaccines·Sofia R GameiroJames W Hodge
Aug 1, 2014·Expert Opinion on Investigational Drugs·Amal H I Al Haddad, Thomas E Adrian
Nov 7, 2012·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Koichiro TsutsumiKazuhide Yamamoto
Apr 30, 2013·Gastroenterology·Andrew Scott PaulsonAndrew M Lowy
Oct 10, 2012·The Journal of Surgical Research·James J Mezhir, Bradley D McDowell
May 19, 2012·Seminars in Oncology·Ravi A MadanJames L Gulley
Dec 6, 2011·Cancer Letters·Si ShiXianjun Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.